Bridger Management, LLC / NKTREUR
Bridger Management, LLC’s Nektar Therapeutics Com New Position
Does Bridger Management, LLC own Nektar Therapeutics Com New (NKTREUR)? Not currently — the last reported position was 1.08M shares worth $39M in Q2 2019; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$39M
Q2 2019
Shares
1.08M
% of Portfolio
+3.03%
Quarters Held
3
position exited
Position History NKTREUR
Reported value by quarter
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bridger Management, LLC’s full portfolio or all institutional holders of NKTREUR.